HLA class II positivity by lysate crossmatch in renal transplant scenario-dangerous if ignored!!!
The detection of antibodies before transplantation is an important step in assessment of patient immunological risk and exclusion of incompatible donors. Many centers have now implemented donor-specific antibody (DSA) along with complement-dependent cytotoxicity crossmatch (CDC XM) for renal transpl...
Main Authors: | Rajesh B Sawant, Pooja Mehta, Deepali Naker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Global Journal of Transfusion Medicine |
Subjects: | |
Online Access: | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2021;volume=6;issue=1;spage=100;epage=102;aulast=Sawant |
Similar Items
-
Luminex-Based Donor-Specific antibody crossmatching for renal transplant: A 3-Year experience in South India
by: Ankit Mathur, et al.
Published: (2018-01-01) -
Successful renal transplantation in a patient with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with chronic kidney disease with complement-dependent cytotoxicity crossmatch positivity (autoantibody induced) and donor-specific antibodies and flow cytometry crossmatch negative
by: G S Kasat, et al.
Published: (2019-01-01) -
Correlation of pretransplant donor-specific antibody assay using luminex crossmatch with graft outcome in renal transplant patients
by: M Vimal, et al.
Published: (2017-01-01) -
Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation
by: Ajay Kumar Baranwal, et al.
Published: (2017-01-01) -
Red cell antibodies resulting in false-positive complement-dependent cytotoxicity cross-match: A unique case
by: Rajesh B Sawant, et al.
Published: (2021-01-01)